Skip to main content
Press Release

Butte nurse charged with unlawfully obtaining opiates from four health care facilities

For Immediate Release
U.S. Attorney's Office, District of Montana

MISSOULA — A Butte nurse suspected of illegally obtaining opiates from four health care facilities in three communities appeared for arraignment on an indictment today, U.S. Attorney Leif M. Johnson said.

Shantyl Marie Giacoletto, 30, pleaded not guilty to four counts of unlawfully obtaining controlled substances. If convicted of the most serious crime, Giacoletto faces a maximum of four years in prison, a $250,000 fine and one year of supervised release.

U.S. Magistrate Judge Kathleen L. DeSoto presided. Giacoletto was detained pending further proceedings.

The indictment alleges that Giacoletto unlawfully obtained oxycodone from Community Hospital of Anaconda from March 2021 to June 2021; unlawfully obtained oxycodone and hydrocodone from Copper Ridge Health and Rehab in Butte from August 2021 to November 2021; unlawfully obtained oxycodone and hydrocodone from Continental Care and Rehabilitation in Butte in October 2021; and unlawfully obtained oxycodone, hydrocodone and morphine from The Ivy in Deer Lodge in November 2021.

An indictment is merely an accusation, and the defendant is presumed innocent until proven guilty beyond a reasonable doubt.

Assistant U.S. Attorney Karla E. Painter is prosecuting the case, which was investigated by the Drug Enforcement Administration and the Anaconda Police Department.

PACER case reference. 22-19.

The progress of cases may be monitored through the U.S. District Court Calendar and the PACER system. To establish a PACER account, which provides electronic access to review documents filed in a case, please visit http://www.pacer.gov/register.html. To access the District Court’s calendar, please visit https://ecf.mtd.uscourts.gov/cgi-bin/PublicCalendar.pl.

XXX

 

 

 

Contact

Clair Johnson Howard
Public Affairs Officer
406-247-4623

Updated May 16, 2022

Topics
Opioids
Prescription Drugs
Press Release Number: 22-130